Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
partnerships
Biotech
Tempest, amid cash drought, hunts for liver cancer drug partner
Unable to secure additional financing amid a stormy market, Tempest has put out a call for partners to help take its liver cancer drug into phase 3.
James Waldron
Apr 10, 2025 7:24am
Charles River and Valo pact nets preclinical lupus asset
Mar 26, 2025 6:30am
Opko, Entera share cost of 1st oral GLP-1/glucagon agonist study
Mar 17, 2025 10:10am
BMS' MyoKardia scraps heart muscle pact with Fulcrum
Mar 5, 2025 5:30am
OS Therapies sets up subsidiary to seek ADC joint ventures
Feb 24, 2025 9:30am
Biotechs behind J&J-bought Yellow Jersey partner on IBD drug
Nov 15, 2024 8:30am
